Retraction notices

Macitentan for the treatment of inoperable chronic thromboembolic pulmonary hypertension (MERIT-1): results from the multicentre, phase 2, randomised, double-blind, placebo-controlled study

Type

Retraction

Notice date

3/26/2024 0:00

Journal

The Lancet Respiratory Medicine

Publisher

Elsevier

Notice DOI

10.1016/s2213-2600(24)00029-8

Original paper DOI

10.1016/s2213-2600(17)30305-3

Reasons

• Concerns/Issues about Data
• Error in Analyses
• Error in Data
• Error in Results and/or Conclusions
• Investigation by Company/Institution
• Investigation by Journal/Publisher
• Investigation by Third Party
• Retract and Replace

Matching venue names

Name match only, not an authoritative journal identifier.

• The Lancet Respiratory Medicine